KOBO BIOTECH LIMITED Share Price

BSE: 531541
|
Pharmaceuticals

₹ 4.35

-₹0.08 (-1.81%)
1D
Last updated 16 Oct, 2026, 14:15 IST

KOBO BIOTECH LIMITED Share Price Today

As of 18 Oct 2026, KOBO BIOTECH LIMITED share price is ₹4.35. The stock opened at ₹4.35, compared to its previous close of ₹4.43. During today's trading session, KOBO BIOTECH LIMITED share price moved in the range of ₹4.35 to ₹4.36, with an average price of ₹4.36 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.99 and a high of ₹9.99.

₹4.35
1.81% down today
₹4.36
1D LOW
1D HIGH

KOBO BIOTECH LIMITED Returns Calculator

Volume
9,716
Average traded price
₹4.35
Last traded time
02:15:00 16 Oct
Last traded quantity
2,500
Circuit
L
H
₹4.27
₹4.43
52-week
L
H
₹1.99
₹9.99
Mkt Cap Cr
10.36
P/E
0.0
P/B
1.14
ROA
-13.19%
ROE
0.0%
ROCE
0.0%
Quick Ratio
0.81
EV/EBITDA
0.0
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Kobo Biotech has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Kobo Biotech appears to be fairly valued compared to its peers
Step 1 of 5
Earnings
Very Poor
Kobo Biotech revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,282.9534.855.0511.19%13.74%17.33%2.3121.41
Divis Laboratories2,44,762.0383.6814.614.6%15.32%19.56%3.555.09
Torrent Pharmaceuticals1,73,447.7480.4520.634.87%25.49%13.85%0.7537.36
Zydus Lifesciences1,12,149.3624.424.148.57%18.59%17.35%0.9114.94
Laurus Labs1,11,250.29102.0320.9910.38%16.77%16.14%0.6854.47
Cipla1,07,042.8631.93.117.92%11.27%14.95%2.518.16
Dr. Reddy's Laboratories1,02,820.0932.32.75.48%11.07%12.54%1.3516.32
Aurobindo Pharma95,512.7325.742.526.34%9.25%11.76%1.1512.27
Mankind Pharma93,967.7645.455.767.36%11.74%13.13%0.7424.75
Lupin89,436.7716.113.9814.47%23.76%24.88%1.429.59

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About KOBO BIOTECH LIMITED

ISIN
INE881A01015
Sector Market Cap
₹ 10.36 Cr

Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company is in the corporate insolvency resolution process.

KOBO BIOTECH LIMITED Financial Highlights

  • Revenue: KOBO BIOTECH LIMITED reported revenue of ₹103.44 crore in FY14 vs ₹404.03 crore in FY13. It showed a decrease of 74.40% on a yearly basis.
  • Operating Profit: KOBO BIOTECH LIMITED reported an operating loss of ₹34.27 crore in FY14 vs ₹14.88 crore in FY13. It showed a decrease of 330.31% on a year-on-year basis.
  • Net Profit: KOBO BIOTECH LIMITED reported a net loss of ₹34.82 crore in FY14 vs ₹13.67 crore in FY13. It showed a decrease of 354.72% on a yearly basis.

KOBO BIOTECH LIMITED Quarterly Result Highlights

  • KOBO BIOTECH LIMITED reported revenue of ₹0.02 crore in Jun 2024, compared with ₹0.00 crore in Mar 2024.
  • KOBO BIOTECH LIMITED reported an operating loss of ₹1.33 crore in Jun 2024, compared with ₹1.26 crore in Mar 2024, representing a decrease of 5.56% on a quarter-on-quarter (QoQ) basis.
  • KOBO BIOTECH LIMITED reported a loss of ₹1.33 crore in Jun 2024, compared with ₹1.26 crore in Mar 2024, reflecting a decrease of 5.56% on a QoQ basis.
  • The earnings per share (EPS) of KOBO BIOTECH LIMITED stood at ₹2.20 during Jun 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
44.95%
FII
0.00%
Other DII
0.00%
Retail and other
55.05%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-1.81%
1 week
-5.23%
1 month
-2.25%
1 year
+72.62%
3 years
+57.04%
5 years
-13.17%
Day
Open / Close
Change %
16 Oct 26
₹4.35 / ₹4.35
-1.81%
15 Oct 26
₹4.43 / ₹4.43
-1.99%
14 Oct 26
₹4.52 / ₹4.52
-1.95%
13 Oct 26
₹4.59 / ₹4.61
-3.96%
Show more

KOBO BIOTECH LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2015Mar 2014Mar 2013Mar 2012
Revenue₹103.19₹403.66₹403.66₹287.26
Other Income₹0.25₹0.37₹0.37₹0.23
Total Revenue₹103.44₹404.02₹404.02₹287.50
Total Expenses₹137.71₹389.15₹389.15₹269.83
Profit Before Tax-₹34.27₹14.87₹14.87₹17.67
Tax₹0.54₹1.21₹1.21₹2.00
Profit After Tax-₹34.82₹13.67₹13.67₹15.67
EPS - Basic-₹15.47₹6.22₹6.22₹6.72
EPS - Diluted-₹15.47₹6.22₹6.22₹6.72

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2015Mar 2014Mar 2013Mar 2012
Profit before tax-₹34.27₹14.87₹14.87₹17.67
Income before WC changes-₹0.67₹43.24₹43.24₹49.11
Change in Assets₹4.12-₹1.73-₹1.73-₹69.41
Change in Liabilities₹3.82-₹3.00-₹3.00₹86.19
Change in WC₹7.94-₹4.74-₹4.74₹16.78
Cash flow from Operations₹6.72₹36.72₹36.72₹63.89
Cash flow from Investing-₹4.71-₹6.99-₹6.99-₹14.43
Cash flow from Financing-₹12.85-₹38.39-₹38.39-₹26.82
Total Cash Flow-₹10.84-₹8.66-₹8.66₹22.64
Cash (Start of the year)₹16.48₹25.13₹25.13₹2.49
Cash (End of the year)₹5.64₹16.48₹16.48₹25.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2015Mar 2014Mar 2013Mar 2012
Non-Current Assets₹105.77₹110.69₹110.69₹113.66
Current Assets₹289.81₹300.99₹300.99₹231.95
Total Assets₹395.58₹411.68₹411.68₹345.61
Current Liabilities₹263.52₹256.48₹256.48₹184.62
Net Current Asset₹26.28₹44.51₹44.51₹47.33
Non-Current Liabilities₹78.98₹67.30₹67.30₹85.34
Equity Capital₹53.08₹87.89₹87.89₹75.66
Total Equity & Liabilities₹395.58₹411.68₹411.68₹345.61

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.08₹0.02₹0.02₹0.02
Total Revenue₹0.08₹0.02₹0.02₹0.02
Total Expenses₹5.31₹4.94₹5.57₹15.24
Profit Before Tax-₹5.23-₹4.93-₹5.55-₹15.23
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹5.23-₹4.93-₹5.55-₹15.23
EPS - Basic-₹2.20-₹2.07-₹2.33-₹6.39
EPS - Diluted-₹2.20-₹2.07-₹2.33-₹6.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹5.23-₹4.93-₹5.55-₹15.23
Income before WC changes-₹1.16-₹0.86-₹1.48-₹10.49
Change in Assets-₹0.09-₹0.08-₹0.22₹120.27
Change in Liabilities₹5.43₹1.14₹2.57-₹16.03
Change in WC₹5.33₹1.06₹2.36₹104.24
Cash flow from Operations₹4.18₹0.20₹0.87₹93.76
Cash flow from Investing₹0.00₹0.00₹0.00₹25.09
Cash flow from Financing₹0.00-₹0.15-₹0.87-₹120.28
Total Cash Flow₹4.18₹0.05₹0.00-₹1.43
Cash (Start of the year)₹0.18₹0.13₹0.13₹1.56
Cash (End of the year)₹4.36₹0.18₹0.13₹0.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹29.44₹33.52₹37.59₹41.66
Current Assets₹42.15₹37.88₹37.74₹37.53
Total Assets₹71.59₹71.39₹75.33₹79.19
Current Liabilities₹173.25₹167.82₹165.88₹163.31
Net Current Asset-₹131.10-₹129.94-₹128.14-₹125.79
Non-Current Liabilities₹36.48₹36.48₹37.43₹38.30
Equity Capital-₹138.14-₹132.91-₹127.98-₹122.43
Total Equity & Liabilities₹71.59₹71.39₹75.33₹79.19
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
4.35
9294
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 9294
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.97
Neutral
ATR (14)
0.17
Neutral
STOCH(9,6)
47.73
Neutral
STOCH RSI (14)
71.21
Neutral
ADX(9)
44.09
Bearish
UO(9)
46.09
Neutral
ROC(12)
15.69
Bullish
WillR(14)
-48.59
Neutral
Period
Simple value
Exponential vaue
5D
4.54
4.44
10D
4.37
4.37
20D
4.15
4.38
50D
4.8
4.9
100D
6.08
5.08
Volume trend — traded volume by day
16 Oct0L
15 Oct0L
14 Oct0L
13 Oct0L
12 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
KOBO BIOTECH LIMITED
Pharmaceuticals
Add Stock
Add Another

KOBO BIOTECH LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.